ICAD - iCAD, Inc. Enterprise Value

iCAD, Inc. (ICAD) implements intelligent systems for the timely detection of breast tumors in hospitals and diagnostic centers. High barriers to entry are ensured by patents, FDA approval, and the integration of software into medical protocols. This chart of current share prices reflects the business valuation at . The issuer's profitability is based on the licensing of AI algorithms and the sale of radiation equipment for surgical procedures.

Enterprise value is calculated as the sum of market capitalization and net debt, determining the actual cost of a full business buyout. This metric allows for an assessment of the real asset value of iCAD, Inc. (ICAD), accounting for the scaling of SaaS subscriptions and AI solutions for oncology centers, which makes the company's total capital level a key indicator of investment attractiveness when analyzing the fundamental trend.